Stock market crash: I’d invest £5,000 in these 2 UK shares in a Stocks and Shares ISA today

These two UK shares could offer defensive appeal after the stock market crash. I’d buy them in a Stocks and Shares ISA right now.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Buying UK shares after the stock market crash may prove to be a risky move in the short run. After all, risks facing the world economy’s future continue to be elevated.

However, a number of FTSE 100 and FTSE 250 stocks appear to offer defensive characteristics. That could help them outperform in a volatile wider stock market.

Here are two prime examples of such companies. They could be worth buying today with £5,000, or any other amount, in a Stocks and Shares ISA on a long-term view.

Long-term growth potential

While the stock market has declined in 2020, not all UK shares have done likewise. For example, the AstraZeneca (LSE: AZN) stock price has gained 11% since the start of the year. Its first quarter update highlighted its growth potential. Years of investment in its pipeline contributed to sales growth of 17% and a rise in core earnings of 21%.

Looking ahead, the company’s defensive business model could become more attractive among investors who are concerned about the economy’s prospects. The business is less reliant on the macroeconomic outlook than many of its FTSE 100 peers. This could mean it’s able to command a rising valuation – especially as its financial performance improves.

Certainly, AstraZeneca’s price-to-earnings (P/E) ratio of around 26 currently places it among the more expensive UK shares available. However, with its bottom line forecast to rise by 26% in the next financial year, it could offer further capital growth potential.

As such, now could be the right time to buy a slice of it in a Stocks and Shares ISA to benefit from its resilient business model and long-term growth prospects.

An income opportunity among UK shares

Another FTSE 100 stock that could offer defensive appeal versus other UK shares is Pennon (LSE: PNN). The utility company’s share price has risen by 6% in 2020. This is significantly higher than the 20% decline among blue-chip shares over the same time period.

The business recently reported a solid financial performance. Although there are regulatory risks facing its future, as well as scope for bad debts caused by a weak economic outlook, its financial outlook appears to be relatively robust. And, with the sale of its Viridor recycling business having been completed, it’s in a position to potentially reduce debt levels to strengthen its financial position.

With Pennon offering a dividend yield of around 3.5%, it’s not among the highest-yielding UK shares available to purchase at present. However, its track record of delivering rising dividends, and the robust nature of its shareholder payouts relative to other FTSE 100 stocks, mean that it could offer income investing appeal. This could boost its share price prospects.

It may also allow it to outperform other large-cap shares during what may prove to be an uncertain period for the stock market.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Peter Stephens owns shares of AstraZeneca. The Motley Fool UK has recommended Pennon Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »